Indian Journal of Medical Specialities Trust
 
Brief Communication
 
Increased urinary cadmium excretion in never-smoking young hypertensive adults in south India – a cross-sectional study
 
Justin Vijay Gnanou*, Brinnell Annette Caszo*, Vinod George Thykadavil**

* Faculty of Medicine, Universiti Teknologi Mara (UiTM), Shah Alam, Malaysia.
** Department of Biochemistry, St. John’s Medical College, Bangalore, India.

Corresponding Author: Dr. Justin V Gnanou, Faculty of Medicine, Universiti Teknologi Mara (UiTM), Shah Alam, Malaysia
Email : gnanou_j@yahoo.com


Abstract

Cadmium toxicity plays an important role in the aetiology of hypertension. Tobacco and occupational exposure to cadmium is the main cause of toxicity in humans. However dietary sources could also play a role in the development of hypertension. Hence in this study, the presence of increased urinary cadmium excretion in hypertensive adults possibly due to dietary sources was studied. Twenty-four hour urine cadmium excretion levels were measured in hypertensive, non-smoking subjects in the age group of 20 – 35 years. Urinary cadmium was measured and the mean 24 hour cadmium excretion in urine was 12.15 μg/day (normal range: 0.00 to 4 μg/day). High levels of urinary cadmium were found in all subjects. Since occupational and smoking causes of cadmium exposure were absent, dietary sources are the likely cause of increased urinary cadmium excretion in these patients.

Key words: Heavy metal toxicity; cadmium poisoning; smoking.

Introduction

In humans, cadmium is known to be toxic. It is absent from the human body at birth and accumulates over the years. A safe intake level has been set at 7 μg/kg body weight. Chronic exposure is associated with various carcinomas, increased risk of diabetes, atherosclerosis and most importantly hypertension. Two studies conducted in the United States indicated a positive correlation between cadmium in drinking water and blood pressure levels [1]. In another study, mortality from hypertension was moderately increased in a village with high cadmium soil levels [2]. Contrastingly, Shigematsu et al showed the prevalence of hypertension in areas of Japan where drinking water and rice were heavily contaminated with cadmium was not greater than in control areas [3]. In two other studies, the levels of cadmium in blood, hair, and renal tissue in normotensive and hypertensive subjects were not different [4,5]. The objective of this study was to determine urinary excretion of cadmium in young individuals with hypertension.

Exposure to cadmium occurs mainly through occupation (mining, battery industries), smoking and dietary intake. High cadmium levels in agricultural soil is attributed to the use of cadmium containing fertilisers [6]. Thus, cadmium enters the food chain and is present in most human food stuffs albeit in varying quantities [7]. Thus our second objective was to establish that dietary sources of cadmium may be an important cause of cadmium
toxicity in south India.

Methods

A total of 35 male hypertensive subjects volunteered to participate in this cross-sectional study. Of these subjects only 15 were between 20-35 years of age, were non-smokers with no occupational exposure to cadmium. These subjects were screened and found negative for pheochromocytoma using 24 hour urinary VMA. Hypertension was defined as systolic pressure ≥ 140 mmHg and/or diastolic pressure ≥ 90 mmHg. Blood pressure was measured using conventional sphygmomanometry. Urinary cadmium was measured using a tomic absorption spectrophotometry. Cadmium level of 0.00 – 4.0 μg/day was considered as the reference range for adults in this study and levels greater than 4.0 μg/day were considered toxic [8]. Ethical approval was obtained from the Institutional Ethical Review Board of St. John’s Medical College, Bangalore and all subjects gave informed consent.

Cadmium in urine was estimated using a flameless atomic absorption spectrophotometer (AAS). Urine samples were diluted 4 times with 0.5% highly
purified nitric acid and the samples were then directly put into the flameless AAS. The within-run CV% and between-run CV% of urinary cadmium estimation was 1.5% and 2.5% respectively.

Linear regression analysis was performed using SPSS 16.0 to analyse the relationship between urinary cadmium excretion and blood pressure measurements.

Results

The mean age of the study group was 29.7 ± 5.4 years. The mean systolic and diastolic blood pressure in these subjects were 147.3 ± 11.0 mmHg and 97.8 ± 7.7 mmHg respectively. The subjects were screened to rule out pheochromocytoma using 24 hour urinary VMA. The mean 24 hour VMA in these subjects was 4.9 ± 2.2 mg/day. 24 hour urinary VMA of less than 7 mg/day ruled out the presence of pheochromocytoma. Cadmium toxicity was explored using 24 hour urinary cadmium levels. The mean cadmium content of the urine in these subjects was 12.2 μg / day and ranged from 4.2 to 30.4 μg/day. Linear regression analysis showed no correlation between 24 hour urinary cadmium levels and systolic (r=0.1) and diastolic blood pressure (r=0.3).

Discussion

Urinary cadmium excretion is considered to be a reliable indicator of cumulative lifetime or long term exposure of cadmium [9]. Our subjects were young, between the ages of 20-35 years and were diagnosed with hypertension. All the subjects in the present study had elevated urinary cadmium levels. Since these patients were non-smokers and had no occupational exposure to cadmium, the source of cadmium was from either water or food.

Chronic low-dose cadmium exposure and its role in the aetiology of hypertension have not been fully elucidated. ‘Oxidative stress’ has been proposed for the development of nephropathy with chronic low dose cadmium exposure. Cadmium was found to induce ‘oxidative stress’ by the generation of hydroxyl radicals and resulted in damage to mitochondria. In addition, cadmium also caused disruption of mitochondrial membrane potential and mitochondrial swelling with the release of cytochrome c and apoptosis [10]. However the mechanism by which cadmium induces a hypertensive phenotype is unknown. In chronic feeding studies in rats, hypertension developed in cadmium exposed rats. These rats also showed increased mortality and marked renal vascular changes [11]. Contrasting results are obtained from human studies. Hypertension was never found among the Japanese Itai itai disease patients who ingested high amounts of cadmium from diet [12]. A study of non-smoking Thai subjects found an
average cadmium concentration of 1.16 μg/L. They faced an 11% increase in probability of having high blood pressure [13].

In the present study, no correlation was found between urinary cadmium excretion and systolic or diastolic blood pressure, which may have been due to a small sample size. However, the findings of this study do indicate the presence of cadmium toxicity in subjects with hypertension, but more importantly this study stresses the importance of the nonoccupational source of cadmium in these subjects. This may be attributed to the continuing
mobilisation of small amounts of the metal toxin from non-bioavailable geologic matrices into biologically accessible situations coupled with increased environmental pollution from industrial waste. These are in addition to the fact that cadmium has a high soil to plant transference rate.

To conclude, young hypertensive non-smoking subjects with no occupational exposure have high cadmium excretion. Future studies based on differing genetic variants of hypertension in larger samplesizes are needed to study the role of chronic cadmium exposure in the aetiopathogenesis of hypertension.

Key Points
  • Cadmium toxicity is associated with hypertension.
  • Cadmium toxicity should be ruled out using urinary cadmium levels in young hypertensives.
  • Dietary sources of cadmium appear to be an important source of chronic cadmium toxicity in South India.

References

  1. Folsom AR, Prineas RJ. Drinking water composition and blood pressure: a review of the epidemiology. Am J Epidemiol 1982;115:818-32.
  2. Inskip H, Beral V, McDowall M. Mortality of Shipham residents: 40-year follow-up. Lancet 1982;1:896-9.
  3. Shigematsu I. Recent trend of environmental pollution in Japan. Southeast Asian J Trop Med Public Health 1979;10:592-9.
  4. Beevers DG, Cruickshank JK, Yeoman WB, Carter GF, Goldberg A, Moore MR. Blood lead and cadmium in human hypertension. J Environ Pathol Toxicol 1980;4:251-60.
  5. Cummins PE, Dutton J, Evans CJ, Morgan WD, Sivyer A, Elwood PC. An in-vivo study of renal cadmium and hypertension. Eur J Clin Invest 1980;10:459-61.
  6. Cadmium in soils and plants. In: McLaughlin MJ, Singh BR (editors). Developments in plant and soil sciences. Dorddrecht-Boston-London: Kluwer Academic Publishers; 1985, p.7.
  7. Galal-Gorchev H. Dietary intake, levels in food and estimated intake of lead, cadmium and mercury. Food Addit Contam 1993;10:115-28
  8. Elinder CG, Lind B, Kjellstrom T, Linnman L, Friberg L. Cadmium in kidney cortex, liver, and pancreas from Swedish autopsies. Estimation of biological half life time in kidney cortex, considering calorie intake and smoking habits. Arch Environ Health 1976;31:292-302.
  9. Lauwerys RR, Bernard AM, Roels HA, Buchet JP. Cadmium: exposure markers as predictors of nephrotoxic effects. Clin Chem 1994;40:1391-
    4.
  10. Robertson JD, Orrenius S. Molecular mechanisms of apoptosis induced by cytotoxic chemicals. Crit Rev Toxicol 2000;30:609-27.
  11. Schroeder HA. Cadmium hypertension in rats. Am J Physiol 1964;207:62-6.
  12. Nakagawa H, Nishijo M. Environmental cadmium exposure, hypertension and cardiovascular risk. J Cardiovasc Risk 1996;3:11-7.
  13. Satarug S, Nishijo M, Ujjin P, Vanavanitkun Y, Moore MR. Cadmium-induced nephropathy in the development of high blood pressure.
 
 
 
Copyright © Indian Journal of Medical Specialities Trust